bioAffinity Technologies, Inc. (BIAF) AI Dilution Summary

Estimated cash was $5,942,630 as of 2026-10-09, rolled forward from $2,429,719 at the 2026-06-30 balance-sheet date against estimated monthly burn of $1,071,391. The most recent raise was a registered direct offering closed 2026-10-09 of 116,545 shares at $6.12, with gross proceeds of $3,996,241, stated as $3,600,000 net. The primary price-linked driver is shelf S-3 333-275608, registered to $25,000,000.